Attached files
file | filename |
---|---|
EX-31.1 - SECTION 302 CEO CFO CERTIFICATE - SYMBOLLON CORP | section302ceocfo_04292010.htm |
10-K/A - AMENDED FORM 10-K FOR 12-31-2009 - SYMBOLLON CORP | amended10k_12312009.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE
OFFICER
AND CHIEF FINANCIAL
OFFICER
PURSUANT TO SECTION
906
OF THE SARBANES-OXLEY ACT OF
2002
In
connection with the Annual Report of Symbollon Pharmaceuticals, Inc. (the
“Company”) on Form 10-K for the period ended December 31, 2009 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Paul C. Desjourdy, Chief Executive Officer and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. |
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
2. |
The
information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the
Company.
|
Date:
April 29, 2010 /s/ Paul C.
Desjourdy
Paul C.
Desjourdy
Chief
Executive Officer and
Chief